These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 34808585)

  • 1. Budesonide associated with exogenous pulmonary surfactant in a novel formulation to improve the delivery to the lung.
    Cimato A; Facorro G; Martínez Sarrasague M
    Respir Physiol Neurobiol; 2022 Feb; 296():103825. PubMed ID: 34808585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose of budesonide with surfactant affects lung and systemic inflammation after normal and injurious ventilation in preterm lambs.
    Hillman NH; Abugisisa L; Royse E; Fee E; Kemp MW; Kramer BW; Schmidt AF; Salomone F; Clarke MW; Musk GC; Jobe AH
    Pediatr Res; 2020 Nov; 88(5):726-732. PubMed ID: 32066138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developing an exogenous pulmonary surfactant-glucocorticoids association: Effect of corticoid concentration on the biophysical properties of the surfactant.
    Cimato A; Facorro G; Martínez Sarrasague M
    Respir Physiol Neurobiol; 2018 Jan; 247():80-86. PubMed ID: 28963086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of intratracheal budesonide during early postnatal life on lung maturity of premature fetal rabbits.
    Li L; Yang C; Feng X; Du Y; Zhang Z; Zhang Y
    Pediatr Pulmonol; 2018 Jan; 53(1):28-35. PubMed ID: 29028158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exogenous Surfactant as a Pulmonary Delivery Vehicle for Budesonide In Vivo.
    Baer B; McCaig L; Yamashita C; Veldhuizen R
    Lung; 2020 Dec; 198(6):909-916. PubMed ID: 33106891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute pathophysiological effects of intratracheal instillation of budesonide and exogenous surfactant in a neonatal surfactant-depleted piglet model.
    Yang CF; Jeng MJ; Soong WJ; Lee YS; Tsao PC; Tang RB
    Pediatr Neonatol; 2010 Aug; 51(4):219-226. PubMed ID: 20713286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the structure and surfactant activity of novel formulations containing exogenous pulmonary surfactant and glucocorticoids.
    Cimato A; Hoyos Obando A; Facorro G; Martínez Sarrasague M
    Respir Physiol Neurobiol; 2016 Nov; 233():33-40. PubMed ID: 27476933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Surfactant Lavage Combined With Intratracheal Budesonide Instillation on Meconium-Injured Piglet Lungs.
    Lin CH; Jeng MJ; Kuo BI; Kou YR
    Pediatr Crit Care Med; 2016 Jun; 17(6):e287-95. PubMed ID: 27124561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversible fatty acid conjugation of budesonide. Novel mechanism for prolonged retention of topically applied steroid in airway tissue.
    Miller-Larsson A; Mattsson H; Hjertberg E; Dahlbäck M; Tunek A; Brattsand R
    Drug Metab Dispos; 1998 Jul; 26(7):623-30. PubMed ID: 9660844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early intratracheal instillation of budesonide using surfactant as a vehicle to prevent chronic lung disease in preterm infants: a pilot study.
    Yeh TF; Lin HC; Chang CH; Wu TS; Su BH; Li TC; Pyati S; Tsai CH
    Pediatrics; 2008 May; 121(5):e1310-8. PubMed ID: 18426851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of intratracheal budesonide-surfactant combined therapy in surfactant-insufficient rat lungs with lipopolysaccharide insult.
    Tsao PC; Lin CH; Lee YS; Chen WY; Jeng MJ; Kou YR
    J Chin Med Assoc; 2021 Aug; 84(8):783-790. PubMed ID: 34155174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of budesonide and its major ester metabolite after inhalation and intravenous administration of budesonide in the rat.
    Jendbro M; Johansson CJ; Strandberg P; Falk-Nilsson H; Edsbäcker S
    Drug Metab Dispos; 2001 May; 29(5):769-76. PubMed ID: 11302946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of surfactant/budesonide therapy on oxidative modifications in the lung in experimental meconium-induced lung injury.
    Mikolka P; Kopincova J; Tomcikova Mikusiakova L; Kosutova P; Antosova M; Calkovska A; Mokra D
    J Physiol Pharmacol; 2016 Feb; 67(1):57-65. PubMed ID: 27010895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thermodynamic and Structural Study of Budesonide-Exogenous Lung Surfactant System.
    Keshavarzi A; Asi Shirazi A; Korfanta R; Královič N; Klacsová M; Martínez JC; Teixeira J; Combet S; Uhríková D
    Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lung deposition and systemic availability of fluticasone Diskus and budesonide Turbuhaler in children.
    Agertoft L; Pedersen S
    Am J Respir Crit Care Med; 2003 Oct; 168(7):779-82. PubMed ID: 12893646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in endogenous esterification and retention in the rat trachea between budesonide and ciclesonide active metabolite.
    Lexmüller K; Gullstrand H; Axelsson BO; Sjölin P; Korn SH; Silberstein DS; Miller-Larsson A
    Drug Metab Dispos; 2007 Oct; 35(10):1788-96. PubMed ID: 17627977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro/in vivo investigation on the potential of Pluronic® mixed micelles for pulmonary drug delivery.
    Pellosi DS; d'Angelo I; Maiolino S; Mitidieri E; d'Emmanuele di Villa Bianca R; Sorrentino R; Quaglia F; Ungaro F
    Eur J Pharm Biopharm; 2018 Sep; 130():30-38. PubMed ID: 29890256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biophysical and chemical stability of surfactant/budesonide and the pulmonary distribution following intra-tracheal administration.
    Chen CM; Chang CH; Chao CH; Wang MH; Yeh TF
    Drug Deliv; 2019 Dec; 26(1):604-611. PubMed ID: 31204848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonged airway activity and improved selectivity of budesonide possibly due to esterification.
    Miller-Larsson A; Jansson P; Runström A; Brattsand R
    Am J Respir Crit Care Med; 2000 Oct; 162(4 Pt 1):1455-61. PubMed ID: 11029361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The wet bridge transfer system: a novel tool to assess exogenous surfactant as a vehicle for intrapulmonary drug delivery.
    Baer B; Veldhuizen EJA; Possmayer F; Yamashita C; Veldhuizen R
    Discov Med; 2018 Nov; 26(144):207-218. PubMed ID: 30695680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.